Anti-parasitic action and elimination of intracellular Toxoplasma gondii in the presence of novel thiosemicarbazone and its 4-thiazolidinone derivatives

Brazilian Journal of Medical and Biological Research

Volumn 43, Issue 2, 2010, Pages 139-149

  Carvalho, C S ^a   De Melo, E J T ^a   Tenorio R P ^b   Goes A J S ^b  

^a UNIVERSIDADE ESTADUAL DO NORTE FLUMINENSE DARCY RIBEIRO   (Brazil)

^b FEDERAL UNIVERSITY OF PERNAMBUCO   (Brazil)

Author keywords

Acid 2 (benzylidene hydrazone) 4 oxo 1,3 thiazolidin 5 yl acetic; Tachyzoite; Toxoplasma; chloro benzaldehyde thiosemicarbazone

Indexed keywords

4 THIAZOLIDINONE DERIVATIVE; THIOSEMICARBAZONE;

ACIDIFICATION; ANIMAL CELL; ANTI PARASITIC ACTION; APOPTOSIS; ARTICLE; BIOASSAY; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; CYTOPLASM; DIGESTION; DRUG ELIMINATION; DRUG MECHANISM; HOST CELL; HOST PARASITE INTERACTION; IN VITRO STUDY; NONHUMAN; PARASITE; TACHYZOITE; TOXOPLASMA GONDII; TOXOPLASMOSIS; VERO CELL;

EUKARYOTA; TOXOPLASMA; TOXOPLASMA GONDII;

EID: 76649098483     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2009005000038     Document Type: Article

References (35)

1. de Melo EJT, de Carvalho TU, de Souza W. Penetration of Toxoplasma gondii into host cells induces changes in the distribution of the mitochondria and the endoplasmic reticulum. Cell Struct Funct 1992; 17: 311-317.
2. Sinai AP, Webster P, Joiner KA. Association of host cell endoplasmic reticulum and mitochondria with the Toxoplasma gondii parasitophorous vacuole membrane: a high affinity interaction. J Cell Sci 1997; 110 (Part 17): 2117-2128.
3. Joiner KA, Fuhrman SA, Miettinen HM, Kasper LH, Mellman I. Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts. Science 1990; 249: 641-646.
4. Mordue DG, Hakansson S, Niesman I, Sibley LD. Toxoplasma gondii resides in a vacuole that avoids fusion with host cell endocytic and exocytic vesicular trafficking pathways. Exp Parasitol 1999; 92: 87-99.
5. Gavin MA, Wanko T, Jacobs L. Electron microscope studies of reproducing and interkinetic Toxoplasma. J Protozool 1962; 9: 222-234.
6. Hu K, Roos DS, Murray JM. A novel polymer of tubulin forms the conoid of Toxoplasma gondii. J Cell Biol 2002; 156: 1039-1050.
7. de Melo EJT, de Souza W. Pathway of C6-NBD-Ceramide on the host cell infected with Toxoplasma gondii. Cell Struct Funct 1996; 21: 47-52.
8. Charron AJ, Sibley LD. Host cells: mobilizable lipid resources for the intracellular parasite Toxoplasma gondii. J Cell Sci 2002; 115: 3049-3059.
9. Sehgal A, Bettiol S, Pypaert M, Wenk MR, Kaasch A, Blader IJ, et al. Peculiarities of host cholesterol transport to the unique intracellular vacuole containing Toxoplasma. Traffic 2005; 6: 1125-1141.
10. Hoagland C. Hematologic complications of cancer chemotherapy. In: Perry MC (Editor), Chemotherapy source book. Baltimore: Williams & Wilkins, 1992. p 498-507.
11. de Melo EJT, Mayerhoffer RO, de Souza W. Hydroxyurea inhibits intracellular Toxoplasma gondii multiplication. FEMS Microbiol Lett 2000; 185: 79-82.
12. Melo EJT, Beiral HJ. Effect of hydroxyurea on the intracellular multiplication of Toxoplasma gondii, Leishmania amazonensis and Trypanosoma cruzi. Braz J Med Biol Res 2003; 36: 65-69.
13. Gwilt PR, Tracewell WG. Pharmacokinetics and pharma-codynamics of hydroxyurea. Clin Pharmacokinet 1998; 34: 347-358.
14. Tenorio RP, Carvalho CS, Pessanha CS, de Lima JG, de Faria AR, Alves AJ, et al. Synthesis of thiosemicarbazone and 4-thiazolidinone derivatives and their in vitro anti-Toxoplasma gondii activity. Bioorg Med Chem Lett 2005; 15: 2575-2578.
15. Bonde CG, Gaikwad NJ. Synthesis and preliminary evaluation of some pyrazine containing thiazolines and thiazolidinones as antimicrobial agents. Bioorg Med Chem 2004; 12: 2151-2161.
16. Rao A, Balzarini J, Carbone A, Chimirri A, De Clercq E, Monforte AM, et al. Synthesis of new 2,3-diaryl-1,3-thiazolidin-4-ones as anti-HIV agents. Farmaco 2004; 59: 33-39.
17. Vigorita MG, Ottana R, Monforte F, Maccari R, Monforte MT, Trovato A, et al. Chiral 3,3'-(1,2-ethanediyl)-bis[2-(3,4-dimethoxyphenyl)-4-thiazolidinones] with anti-inflammatory activity. Part 11: evaluation of COX-2 selectivity and modelling. Bioorg Med Chem 2003; 11: 999-1006.
18. Ergenc N, Capan G, Gunay NS, Ozkirimli S, Gungor M, Ozbey S, et al. Synthesis and hypnotic activity of new 4-thiazolidinone and 2-thioxo-4,5- imidazolidinedione derivatives. Arch Pharm 1999; 332: 343-347.
19. Alves AJ, Leite AC, De Santana DP, Beltrao TM, Coelho MR, Gayral P. Synthesis of some 4-oxo-delta 2-thiazolin-2-ylhydrazones as potential antiprotozoal agents. Farmaco 1993; 48: 1167-1171.
20. Seebacher W, Brun R, Weis R. New 4-aminobicyclo[2.2.2] octane derivatives and their activities against Plasmodium falciparum and Trypanosoma b. rhodesiense. Eur J Pharm Sci 2004; 21: 225-233.
21. Djurkovic-Djakovic O, Nikolic T, Robert-Gangneux F, Bobic B, Nikolic A. Synergistic effect of clindamycin and atovaquone in acute murine toxoplasmosis. Antimicrob Agents Chemother 1999; 43: 2240-2244.
22. Chirgwin K, Hafner R, Leport C, Remington J, Andersen J, Bosler EM, et al. Randomized phase II trial of atova-quone with pyrimethamine or sulfadiazine for treatment of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome: ACTG 237/ANRS 039 Study. AIDS Clinical Trials Group 237/Agence Nationale de Recherche sur le SIDA, Essai 039. Clin Infect Dis 2002; 34: 1243-1250.
23. Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet 2004; 363: 1965-1976.
24. Kielian MC, Cohn ZA. Phagosome-lysosome fusion. Characterization of intracellular membrane fusion in mouse macrophages. J Cell Biol 1980; 85: 754-765.
25. Carvalho CS, Melo EJT. Acidification of the parasitophorous vacuole containing Toxoplasma gondii in the presence of hydroxyurea. An Acad Bras Cienc 2006; 78: 475-484.
26. Vieites M, Otero L, Santos D, Toloza J, Figueroa R, Norambuena E, et al. Platinum(II) metal complexes as potential anti-Trypanosoma cruzi agents. J Inorg Biochem 2008; 102: 1033-1043.
27. Abid M, Agarwal SM, Azam A. Synthesis and antiamoebic activity of metronidazole thiosemicarbazone analogues. Eur J Med Chem 2008; 43: 2035-2039.
28. Biot C, Pradines B, Sergeant MH, Gut J, Rosenthal PJ, Chibale K. Design, synthesis, and antimalarial activity of structural chimeras of thiosemicarbazone and ferroquine analogues. Bioorg Med Chem Lett 2007; 17: 6434-6438.
29. Casas JS, Garcia-Tasende MS, Sordo J. Main group metal complexes of semicarbazones and thiosemicarbazones. A structural review. Coord Chem Rev 2000; 209: 197-261.
30. Bharti N, Husain K, Gonzalez Garza MT, Cruz-Vega DE, Castro-Garza J, Mata-Cardenas BD, et al. Synthesis and in vitro antiprotozoal activity of 5-nitrothiophene-2-carboxaldehyde thiosemicarbazone derivatives. Bioorg Med Chem Lett 2002; 12: 3475-3478.
31. Finch RA, Liu MC, Cory AH, Cory JG, Sartorelli AC. Triapine(3- aminopyridine-2-carboxaldehydethiosemicarbazone; 3-AP): an inhibitor of ribonucleotide reductase with antineoplastic activity. Adv Enzyme Regul 1999; 39: 3-12.
32. Vejux A, Kahn E, Dumas D, Bessede G, Menetrier F, Athias A, et al. 7-Ketocholesterol favors lipid accumulation and colocalizes with Nile Red positive cytoplasmic structures formed during 7-ketocholesterol-induced apoptosis: analysis by flow cytometry, FRET biphoton spectral imaging microscopy, and subcellular fractionation. Cytometry A 2005; 64: 87-100.
33. Ling YM, Shaw MH, Ayala C, Coppens I, Taylor GA, Ferguson DJ, et al. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J Exp Med 2006; 203: 2063-2071.
34. Sinai AP, Joiner KA. The Toxoplasma gondii protein ROP2 mediates host organelle association with the parasito-phorous vacuole membrane. J Cell Biol 2001; 154: 95-108.
35. Beckers CJ, Dubremetz JF, Mercereau-Puijalon O, Joiner KA. The Toxoplasma gondii rhoptry protein ROP 2 is inserted into the parasitophorous vacuole membrane, surrounding the intracellular parasite, and is exposed to the host cell cytoplasm. J Cell Biol 1994; 127: 947-961.